PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -98.8% | 306 | -98.8% | 0.00% | – |
| Q1 2022 | $80,000 | -50.9% | 25,706 | 0.0% | 0.00% | – |
| Q4 2021 | $163,000 | -36.6% | 25,706 | -0.3% | 0.00% | – |
| Q3 2021 | $257,000 | -39.4% | 25,785 | -19.5% | 0.00% | – |
| Q2 2021 | $424,000 | +7.9% | 32,024 | +42.3% | 0.00% | – |
| Q1 2021 | $393,000 | -18.3% | 22,500 | +19.7% | 0.00% | -100.0% |
| Q4 2020 | $481,000 | +193.3% | 18,800 | +50.4% | 0.00% | – |
| Q3 2020 | $164,000 | -52.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2020 | $342,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
| BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
| Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
| Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
| Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
| Annandale Capital, LLC | 54,338 | $51 | 0.02% |